PMC:7152526 / 311-808 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"16","span":{"begin":146,"end":154},"obj":"Species"},{"id":"19","span":{"begin":46,"end":62},"obj":"Disease"},{"id":"20","span":{"begin":89,"end":97},"obj":"Disease"},{"id":"21","span":{"begin":172,"end":181},"obj":"Disease"},{"id":"22","span":{"begin":187,"end":222},"obj":"Disease"},{"id":"23","span":{"begin":420,"end":428},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"Tax:9606"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D001102"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:C000657245"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"MESH:D011014"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"MESH:D012128"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.\n\nGraphical Abstract\n\nINTRODUCTION\nAn outbreak of severe ac"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":124,"end":130},"obj":"Body_part"},{"id":"T4","span":{"begin":284,"end":290},"obj":"Body_part"},{"id":"T5","span":{"begin":401,"end":407},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"ival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.\n\nGraphical Abstract\n\nINTRODUCTION\nAn outbreak of severe ac"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":46,"end":62},"obj":"Disease"},{"id":"T9","span":{"begin":89,"end":97},"obj":"Disease"},{"id":"T10","span":{"begin":172,"end":181},"obj":"Disease"},{"id":"T11","span":{"begin":187,"end":222},"obj":"Disease"},{"id":"T12","span":{"begin":193,"end":222},"obj":"Disease"},{"id":"T13","span":{"begin":420,"end":428},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.\n\nGraphical Abstract\n\nINTRODUCTION\nAn outbreak of severe ac"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":124,"end":130},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T6","span":{"begin":234,"end":235},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T7","span":{"begin":284,"end":290},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T8","span":{"begin":401,"end":407},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"ival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.\n\nGraphical Abstract\n\nINTRODUCTION\nAn outbreak of severe ac"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":315,"end":329},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"ival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.\n\nGraphical Abstract\n\nINTRODUCTION\nAn outbreak of severe ac"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":46,"end":62},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"ival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.\n\nGraphical Abstract\n\nINTRODUCTION\nAn outbreak of severe ac"}

{"project":"LitCovid-sentences","denotations":[{"id":"T4","span":{"begin":64,"end":140},"obj":"Sentence"},{"id":"T5","span":{"begin":141,"end":330},"obj":"Sentence"},{"id":"T6","span":{"begin":331,"end":438},"obj":"Sentence"},{"id":"T7","span":{"begin":440,"end":458},"obj":"Sentence"},{"id":"T8","span":{"begin":460,"end":472},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.\n\nGraphical Abstract\n\nINTRODUCTION\nAn outbreak of severe ac"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":172,"end":181},"obj":"Phenotype"},{"id":"T3","span":{"begin":193,"end":213},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"ival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.\n\nGraphical Abstract\n\nINTRODUCTION\nAn outbreak of severe ac"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T9","span":{"begin":46,"end":51},"obj":"NCBITaxon:10239"},{"id":"T10","span":{"begin":89,"end":97},"obj":"SP_7"},{"id":"T11","span":{"begin":124,"end":130},"obj":"UBERON:0001969"},{"id":"T12","span":{"begin":193,"end":204},"obj":"UBERON:0001004"},{"id":"T13","span":{"begin":284,"end":290},"obj":"UBERON:0001969"},{"id":"T14","span":{"begin":315,"end":329},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T15","span":{"begin":401,"end":407},"obj":"UBERON:0001969"},{"id":"T16","span":{"begin":420,"end":428},"obj":"SP_7"},{"id":"T89918","span":{"begin":46,"end":51},"obj":"NCBITaxon:10239"},{"id":"T68910","span":{"begin":89,"end":97},"obj":"SP_7"},{"id":"T66646","span":{"begin":124,"end":130},"obj":"UBERON:0001969"},{"id":"T33202","span":{"begin":193,"end":204},"obj":"UBERON:0001004"},{"id":"T85214","span":{"begin":284,"end":290},"obj":"UBERON:0001969"},{"id":"T61698","span":{"begin":315,"end":329},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T26474","span":{"begin":401,"end":407},"obj":"UBERON:0001969"},{"id":"T87558","span":{"begin":420,"end":428},"obj":"SP_7"}],"text":"ival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.\n\nGraphical Abstract\n\nINTRODUCTION\nAn outbreak of severe ac"}